Author Correction: Dopamine-dependent prefrontal reactivations explain long-term benefit of fear extinction.
Where this comes from
- Record sourced from PubMed, PMID 30674882.
- Also identified by DOI 10.1038/s41467-019-08399-4 and PMC identifier 6344470.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the original version of this Article, the fourth sentence of the legend to Figure 1b incorrectly read "Note, that the group difference stemmed from significantly smaller CS+ evoked SCRs averaged across the whole test phase, but the speed of re-extinction did not differ significantly between drug groups (control analysis with stimulus (CS+, CS-) and trial (1-10) as within-, and group (placebo, L-DOPA) as between-subject factor: stimulus × group, F1,297 = 6.57, P = 0.02, partial η2 = 0.17; stimulus × trial × group, F1,297 = 1.32, P = 0.23; n = 35)". The correct version states "F1,33 = 6.58" instead of "F1,297 = 6.57", and "F9,297 = 1.32" instead of "F1,297 = 1.32". These errors have now been corrected in both the PDF and HTML versions of the Article. The correct values were used in the statistical analysis and the errors do not affect the conclusions.